David Kotler

David Kotler

Dechert LLP

Contact  |  View Bio  |  RSS

Latest Posts › Securities Fraud

Share:

Dechert Survey of Securities Fraud Class Actions Brought Against U.S. Life Sciences Companies

Publicly Traded Life Sciences Companies in the United States Are an Increasingly Popular Target of Securities Fraud Class Action Lawsuits - The past year was particularly noteworthy with respect to the relative number...more

3/19/2015 - Biotechnology Class Action Compliance Disclosure Requirements Insider Trading Life Sciences Medical Devices Misrepresentation Pharmaceutical Manufacturers Popular Publicly-Traded Companies Rule 10b-5 Securities Fraud Surveys

Dechert Survey of Securities Fraud Class Actions Brought Against U.S. Life Sciences Companies

Publicly Traded Life Sciences Companies in the United States Remain an Increasingly Popular Target of Securities Fraud Class Action Lawsuits: The past year was particularly noteworthy with respect to the absolute and...more

3/20/2013 - Amgen Inc. v Connecticut Retirement Plans Class Action FDA Fraud Life Sciences Marketing Off-Label Promotion Pharmaceutical Securities Fraud

2 Results
|
View per page
Page: of 1

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×